Table 2 Distribution of included disorder established treatment studies
From: Mapping the evidence for the prevention and treatment of eating disorders in young people
| Intervention | Trial | AN | BN | BED | EDNOS | Review | |
|---|---|---|---|---|---|---|---|
| Psychological | Cognitive & behavioural therapies | 27 | 3 | 22 | 2 | 5 | |
| Psychoeducation | 10 | 6 | 6 | ||||
| Family based therapy (FBT) | 15 | 12 | 5 | 2 | 5 | ||
| Supportive therapy | 3 | 1 | 3 | ||||
| Psychodynamic/Psychoanalysis | 5 | 1 | 3 | 1 | |||
| Motivational interview/enhancement | 4 | 2 | 3 | 1 | 3 | ||
| Exposure therapy | 2 | 2 | |||||
| Interpersonal therapy | 2 | 2 | |||||
| Dialectical behavioural therapy | 1 | 1 | |||||
| Eye movement desens. & reprocessing | 1 | 1 | 1 | 1 | |||
| Psychological - other | 27 | 14 | 18 | 2 | 6 | ||
| Psychological - general | 4 | ||||||
| Biological | SSRI | 15 | 4 | 9 | 1 | 1 | |
| TCA | 10 | 3 | 8 | ||||
| SNRI | 1 | 1 | |||||
| MAOI | 1 | 1 | |||||
| Appetite moderator | 6 | 1 | 5 | 1 | |||
| Anticonvulsant | 1 | 1 | |||||
| Typical antipsychotic | 1 | 1 | 2 | ||||
| Atypical antipsychotic | 6 | 6 | 1 | 3 | |||
| Lithium | 2 | 1 | 1 | ||||
| Antidepressant - other (trazodone) | 1 | 1 | |||||
| Opioid antagonist (naltrexone) | 1 | 1 | |||||
| Neutraceutical (inositol) | 1 | 1 | 1 | ||||
| Transcranial magnetic stimulation | 1 | 1 | |||||
| Re-feeding | 2 | 2 | |||||
| Biological - other | 4 | 3 | 1 | ||||
| Biological - general | 4 | ||||||
| Service | Service/Delivery improvement | 6 | 3 | 4 | 1 |
